Mar 2014 $4 M Private placement after listing $2 to $10 million 3
Biotime Inc.: Private sale, Mar 2014 × Investors in this round 3 investors had bought by the notice of Mar 7, 2014: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $15 M offered; $12 M still to sell
Smallest investment taken $500,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in California People named in the notice Michael D West · Executive Officer, Director Robert W Peabody · Executive Officer William P. Tew · Executive Officer Alfred D Kingsley · Director Andrew C. von Eschenbach · Director Franklin M. Berger · Director Henry L. Nordhoff · Director Judith D Segall · Director Neal C Bradsher · Director Pedro D Lichtinger · Director Stephen C. Farrell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Judith Segall, Corporate Secretary. Source: SEC Form D, newest notice filed Mar 7, 2014. Read the notice at the SEC .
equity, options SEC Mar 2011 $4 M Issued in a merger or acquisition $2 to $10 million 20
Biotime Inc.: Private sale, Mar 2011 × Investors in this round 20 investors had bought by the notice of Mar 24, 2011: 19 accredited, 1 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in California People named in the notice Judith D Segall · Executive Officer, Director Michael D West · Executive Officer, Director Robert W Peabody · Executive Officer Walter W Funk · Executive Officer Abraham E Cohen · Director Alfred D Kingsley · Director Arnold I Burns · Director Neal C Bradsher · Director Pedro D Lichtinger · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Shares and warrants issued in merger”Signed by Judith Segall, Corporate Secretary. Source: SEC Form D, newest notice filed Mar 24, 2011. Read the notice at the SEC .
equity, options SEC Jan 2011 $2 M Issued in a merger or acquisition $2 to $10 million 8
Biotime Inc.: Private sale, Jan 2011 × Investors in this round 8 investors had bought by the notice of Feb 2, 2011: 6 accredited, 2 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 505: the former limited-offering exemption (withdrawn in 2017) 06
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in California People named in the notice Judith D Segall · Executive Officer, Director Michael D West · Executive Officer, Director Robert W Peabody · Executive Officer Walter W Funk · Executive Officer Abraham E Cohen · Director Alfred D Kingsley · Director Arnold I Burns · Director Neal C Bradsher · Director Pedro D Lichtinger · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Shares issued in exchange for assets”Signed by Judith Segall, Corporate Secretary. Source: SEC Form D, newest notice filed Feb 2, 2011. Read the notice at the SEC .
equity SEC May 2010 $8 M No. 3 $2 to $10 million 2
Biotime Inc.: Raise no. 3, May 2010 × Investors in this round 2 investors had bought by the notice of May 21, 2010: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken $4,000,000
What was sold equity
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in California People named in the notice Michael D West · Executive Officer, Director Robert W Peabody · Executive Officer Steven A Seinberg · Executive Officer Walter W Funk · Executive Officer Abraham E Cohen · Director Alfred D Kingsley · Director Arnold I Burns · Director Judith D Segall · Director Neal C Bradsher · Director Pedro D Lichtinger · Director Robert N Butler · Director Valeta A Gregg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “4,400,000 shares at $1.818 per share”Signed by Robert Peabody, Chief Operating Officer. Source: SEC Form D, newest notice filed May 21, 2010. Read the notice at the SEC .
equity SEC May 2009 $8 M No. 2 $2 to $10 million 2
Biotime Inc.: Raise no. 2, May 2009 × Investors in this round 2 investors had bought by the notice of Jul 14, 2009: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $17 M offered; $9 M still to sell
Smallest investment taken $2,000,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in California People named in the notice Hal Sternberg · Executive Officer, Director Harold Waitz · Executive Officer, Director Judith Segall · Executive Officer, Director Michael D West · Executive Officer, Director Robert W Peabody · Executive Officer Steven A Seinberg · Executive Officer Abraham E Cohen · Director Alfred D Kingsley · Director Arnold I Burns · Director Neal C Bradsher · Director Robert N Butler · Director Valeta Gregg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Remaining amount issuable upon exercise of warrants.”Signed by Steven A Seinberg, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 14, 2009. Read the notice at the SEC .
equity, options SEC Apr 2009 $4 M No. 1 $2 to $10 million 29
Biotime Inc.: Raise no. 1, Apr 2009 × Investors in this round 29 investors had bought by the notice of May 21, 2009: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity, debt
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions $23,000
Finders' fees $5,000
Paid to its own people $625,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company Corporation, incorporated in Ca People named in the notice Hal Sternberg · Executive Officer, Director Harold Waitz · Executive Officer, Director Judith Segall · Executive Officer, Director Michael D West · Executive Officer, Director Robert W Peabody · Executive Officer Steven A Seinberg · Executive Officer Gregg Valeta · Director Robert N Butler · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round unknown · broker-dealer Equity Source Partners (CRD 140227) · Jericho, Ny Sold in no state named Robert Kingsley · Chicago, Il Sold in no state named Remarks in the notice On fees: “Plus warrants to purchase common stock”On the amounts: “Revolving Line of Credit”On the use of proceeds: “Salary payments”Signed by Steven A Seinberg, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed May 21, 2009. Read the notice at the SEC .
equity, debt SEC